-
EP4659818
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4659818
| EP4659818 - TREATMENT METHOD AND PRODUCT FOR UTERINE FIBROIDS USING PURIFIED COLLAGENASE [Right-click to bookmark this link] | Status | The application has been published Status updated on 07.11.2025 Database last updated on 08.04.2026 | Most recent event Tooltip | 13.03.2026 | New entry: Renewal fee paid | Applicant(s) | For all designated states Endo Biologics Limited First Floor, Minerva House Simmonscourt Road Ballsbridge Dublin 4, D04H9P8 / IE | For all designated states Duke University 2138 Campus Drive Durham, North Carolina 27708 / US | [2025/51] |
| Former [2025/50] | For all designated states BioSpecifics Technologies Corporation 35 Wilbur Street Lynbrook, NY 11563 / US | ||
| For all designated states Duke University 2138 Campus Drive Durham, North Carolina 27708 / US | Inventor(s) | 01 /
LEPPERT, Phyllis Carolyn Durham, 27705 / US | 02 /
WEGMAN, Thomas L New York, 11566 / US | [2025/50] | Representative(s) | Abel & Imray LLP Westpoint Building James Street West Bath BA1 2DA / GB | [2025/50] | Application number, filing date | 25180240.1 | 14.03.2014 | [2025/50] | Priority number, date | US201361790070P | 15.03.2013 Original published format: US 201361790070 P | [2025/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP4659818 | Date: | 10.12.2025 | Language: | EN | [2025/50] | Type: | A3 Search report | No.: | EP4659818 | Date: | 04.03.2026 | Language: | EN | [2026/10] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 30.01.2026 | Classification | IPC: | A61K38/48, A61P35/00, A61K9/00, A61K38/43, A61K45/06, A61P15/00, A61P43/00 | [2026/10] | CPC: |
A61K38/4886 (EP,US);
A61K9/48 (US);
A61K38/43 (EP,US);
A61K45/06 (EP,US);
A61K9/0019 (EP,US);
A61K9/0034 (EP,US);
A61K9/1075 (US);
A61P15/00 (EP);
A61P35/00 (EP);
| C-Set: |
A61K38/4886, A61K2300/00 (EP,US)
|
| Former IPC [2025/50] | A61P43/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2025/50] | Title | German: | BEHANDLUNGSVERFAHREN UND MITTEL FÜR GEBÄRMUTTERFIBROIDEN UNTER VERWENDUNG GEREINIGTER KOLLAGENASE | [2025/50] | English: | TREATMENT METHOD AND PRODUCT FOR UTERINE FIBROIDS USING PURIFIED COLLAGENASE | [2025/50] | French: | PROCÉDÉ ET PRODUIT DE TRAITEMENT DE FIBROMES UTÉRINS À L'AIDE DE COLLAGÉNASE PURIFIÉE | [2025/50] | Parent application(s) Tooltip | EP14721664.2 / EP2968484 | EP20201646.5 / EP3834840 | Fees paid | Renewal fee | 31.07.2025 | Renewal fee patent year 03 | 31.07.2025 | Renewal fee patent year 04 | 31.07.2025 | Renewal fee patent year 05 | 31.07.2025 | Renewal fee patent year 06 | 31.07.2025 | Renewal fee patent year 07 | 31.07.2025 | Renewal fee patent year 08 | 31.07.2025 | Renewal fee patent year 09 | 31.07.2025 | Renewal fee patent year 10 | 31.07.2025 | Renewal fee patent year 11 | 31.07.2025 | Renewal fee patent year 12 | 12.03.2026 | Renewal fee patent year 13 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY] WO2006121968 (BOSTON SCIENT SCIMED INC et al.) | [Y] WO2012031245 (UNIV NORTH CAROLINA et al.) | [XY] F. L. JAVES ET AL: "TREATMENT OF UTERINE FIBROIDS WITH HIGHLY PURIFIED CLOSTRIDIAL COLLAGENASE", FERTILITY AND STERILITY, vol. 98, no. 3, 25 August 2012 (2012-08-25), pages S232, XP055127058, DOI: 10.4137/CMT.S3331 DOI: http://dx.doi.org/10.4137/CMT.S3331 | [Y] DARLENE K. TAYLOR ET AL: "Treatment for uterine fibroids: Searching for effective drug therapies", DRUG DISCOVERY TODAY: THERAPEUTIC STRATEGIES, vol. 9, no. 1, 10 August 2012 (2012-08-10), pages e41 - e49, XP055127057, ISSN: 1740-6773, DOI: 10.1016/j.ddstr.2012.06.001 DOI: http://dx.doi.org/10.1016/j.ddstr.2012.06.001 | [XI] DARLENE TAYLOR ET AL: "Putting the Moose on the Table: Understanding the Molecular Biology of Uterine Fibroids and Development of Non-invasion Treatments", 28 October 2012 (2012-10-28), XP055257658, Retrieved from the Internet | DARLENE K. TAYLOR ET AL: "Recent scientific advances in leiomyoma (uterine fibroids) research facilitates better understanding and management", F1000RESEARCH, 6 July 2015 (2015-07-06), XP055257667, DOI: 10.12688/f1000research.6189.1 DOI: http://dx.doi.org/10.12688/f1000research.6189.1 | [Y] TAYLOR D K ET AL: "Temperature-responsive biocompatible copolymers incorporating hyperbranched polyglycerols for adjustable functionality", JOURNAL OF FUNCTIONAL BIOMATERIALS, M D P I AG, CH, vol. 2, 1 January 2011 (2011-01-01), pages 173 - 194, XP009165596, ISSN: 2079-4983, [retrieved on 20110823] DOI: http://dx.doi.org/10.3390/jfb2030173 | by applicant | US7811560 | US2010086971 | US6565530 | US6544227 | US10083003 | FENG LLEIKIN S ET AL., XXIIND MEETING OF THE FEDERATION OF EUROPEAN CONNECTIVE TISSUE SOCIETIES (FECTS, 3 July 2010 (2010-07-03) | LEPPERT ET AL.: "A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays", AM J OBSTET GYN, vol. 95, 2006, pages 415 - 20, XP005587597, DOI: 10.1016/j.ajog.2005.12.059 DOI: http://dx.doi.org/10.1016/j.ajog.2005.12.059 | HINZGABBIANI, CURRENT OPINIONS IN BIOTECHNOLOGY, vol. 14, 2003, pages 38 - 46 | CATHERINO, GENES, CHROMOSOMES & CANCER, vol. 40, 2004, pages 204 - 217 |